The Regulatory System May Not Be Ready for Synthetic Organisms
By Susana Medeiros,
RegBlog
| 07. 15. 2015
Untitled Document
Scientists are working on synthetically designed microorganisms that may soon produce everything from the fuel in your gas tank to your Spandex. Distinct from genetically modified organisms, which are created by the transfer of small amounts of genetic material, synthetic biology allows scientists to assemble entirely new organisms that may be more efficient than those naturally occurring in nature.
Some of these organisms can even function as tiny factories to produce rare and expensive chemicals and compounds. For example, Exxon expects to spend over $600 million towards the development of synthetic algae that may serve as an alternative biofuel over the next decade. Synthetic organisms could even be designed specifically to be released into the environment and consume carbon dioxide, mollifying the effects of global warming.
However, despite its potential advantages, synthetic biology could also produce dangers that are not met by the nation’s current regulatory system, according to a recent article by law professors Gregory N. Mandel and Gary E. Marchant.
Synthetic biology is currently regulated based on its use, typically by the U.S. Environmental Protection...
Related Articles
By Jorge Barrera and Rachel Houlihan, CBC | 04.09.2024
A Canadian DNA laboratory knowingly delivered prenatal paternity test results that routinely identified the wrong biological fathers — ruling out the real dads — and left a trail of shattered lives around the globe, a CBC News investigation has found...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Jason Kehe, Wired | 04.11.2024
God help the babies! Or, absent God, a fertility startup called Orchid. It offers prospective parents a fantastical choice: Have a regular baby or have an Orchid baby. A regular baby might grow up and get cancer. Or be born...